Industry News

Quest Diagnostics, the world's leading provider of diagnostic services, announced today that the U.S. Department of Health and Human Services has authorized the company to perform drug testing using electronic Custody and Control Forms for federally-mandated, safety-sensitive workers. With the approval, Quest becomes the largest workplace drug testing provider certified to provide Federal eCCF, which can enhance efficiencies and..."/>
Quest Diagnostics Approved to Use Electronic Drug Test Process for Federally-Mandated Workforce by U.S. Health and Human Services
CoLucid Pharmaceuticals, Inc.,, at www.colucid.com. CoLucid is a Phase 3 clinical-stage biopharmaceutical company developing lasmiditan oral tablets for the acute treatment of migraine in adults. "CoLucid's objective is to provide key information to three core stakeholder groups: prospective..."/>
King Fish Media Announces Website Launch for CoLucid Pharmaceuticals
MGT Capital Investments, Inc., announced that John McAfee, the Company's proposed Executive Chairman and Chief Executive Officer, delivered an important and well-received keynote address at the Fourth Internet Security Conference in Beijing on Tuesday, August 16, 2016 at the China National Convention Center. He was joined by more than 100 presenters representing over 70 global networks of security-related institutions and..."/>
John McAfee at the China Internet Security Conference 2016
Aphria Inc. is pleased to announce it has closed its short form prospectus offering, on a bought deal basis, including the exercise in full of the underwriters' over-allotment option. A total of 17,250,000 common shares of the Company were sold at a price of $2.00 per Share, for aggregate gross proceeds of $34,500,000."/>
Aphria Announces Closing of Bought Deal Financing
Kadimastem announced today that following success in the first stage of trials held under the agreement entered on November 24, 2015, an addendum was signed which sets out the timetable for starting feasibility studies in animals in the course of next month. The first stage involved joint trials in which optimization of the conditions was carried out and it was shown that the insulin-secreting..."/>
Following Successful First Stage in Trial: Kadimastem Signed Agreement with Medical Device Company to Expand Joint Trials of Diabetes Therapy using Unique Encapsulation Device
DigiPath Labs, a subsidiary of DigiPath, Inc., an independent cannabis testing lab and media firm, is pleased to announce it has been selected as the laboratory testing service provider for The Clinic Nevada, LLC, a licensed cannabis cultivator, producer, and dispenser located in Las Vegas, Nevada. The Clinic has numerous retail and cultivation locations in Colorado and Illinois. The Clinic Nevada is excited to launch sub-brands, The Lab concentrates and The..."/>
DigiPath Selected as Laboratory Testing Service Provider for The Clinic Nevada
Kiwa Bio-Tech Products Group Corporation: On August 18, 2016 Kiwa Bio-Tech Products Group Corporation reported its operating results for its second quarter ended June 30, 2016. For the second quarter, Kiwa reported revenue of $443,085 and net income of $181,975. For the first six months of fiscal 2016, Kiwa reported revenue of $710,095 and net income of $238,105.. Yvonne Wang, stated, "We are pleased to see that Kiwa has achieved revenue growth and..."/>
Kiwa Bio-Tech Products Group Corporation Reports 217% Increase in 2016 Second Quarter Net Profit
Chembio Diagnostics, Inc., a leader in point-of-care diagnostic tests for infectious diseases, today announced that the Company has entered into an exclusive distribution agreement with Isla Lab Caribbean, which covers twenty-five nations in the Caribbean, excluding Puerto Rico and the U.S. The exclusive distribution agreement with Isla Lab Caribbean initially includes Chembio’ s current products, which have met regulatory requirements to be..."/>
Chembio Expands Product Distribution through Exclusive Agreement with Isla Lab in the Caribbean
Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for rare diseases, today announced the pricing of its underwritten public offering of 1,250,000 shares of its common stock at a price to the public of $16.00 per share, before underwriting discounts and commissions. All of the shares of common stock to be sold in the offering are to be sold..."/>
Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders, will present at the Rodman& Renshaw 18th Annual Global Investment Conference on Tuesday, September 13 from 3:00 to 3:25 pm ET. Roger Crystal, Chief Executive Officer, and Kevin Pollack, Chief Financial Officer, will be delivering an overview of the company and updating investors on the..."/>
Opiant Pharmaceuticals to Present at the Rodman & Renshaw Conference on September 13 in New York City
Nightingale Informatix Corporation today announced that the cease trade order issued by the Ontario Securities Commission dated August 5, 2016, has been revoked. The Company filed its audited annual consolidated financial statements as at and for the years ended March 31, 2016 and 2015, related management discussion and analysis and applicable officer certifications on August 12, 2016. The materials can be..."/>
Nightingale Announces Revocation of Cease Trade Order
SQI Diagnostics Inc., today reported its financial and operational results for the three and nine months ended June 30, 2016.. SQI is a Toronto-based life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced multiplexed diagnostics. Said Andrew Morris, SQI's President and CEO: "Our transformation from an R&D company to a company with recurring revenue is accelerating."/>
SQI Diagnostics Reports Third Quarter 2016 Results
PositiveID Corporation, a life sciences company focused on detection and diagnostics, announced today that it will present and exhibit as a premier sponsor at the Next Generation Dx Summit from August 23-26, 2016, at the Grand Hyatt Washington in Washington, D.C. PositiveID’ s President, Lyle L. Probst, will feature the Company’ s E-N-G Mobile Systems subsidiary, a leader in mobile laboratories, in his presentation:“ Mobile Labs: Bringing Labs to the Point..."/>
PositiveID to Present and Exhibit at the Next Generation Dx Summit August 23-26
Akorn, Inc., a leading specialty generic pharmaceutical company, today announced that Rob Monahan has recently joined Akorn as Senior Vice President of Corporate Development.. Monahan joins Akorn from Walgreens Boots Alliance, Inc., where he was a corporate development professional focused on Mergers& Acquisitions since 2009, most recently as Vice President of Mergers& Acquisitions. At Walgreens, he was responsible for developing and executing..."/>
Akorn Appoints Robert Monahan as Senior Vice President of Corporate Development
Diffusion Pharmaceuticals Inc., a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer and other hypoxia-related diseases, today announced that its Board of Directors approved an amendment to the Company's certificate of incorporation effecting a 1- for-10 reverse split of all outstanding common stock. Diffusion’ s stockholders previously approved the reverse split on July..."/>
Diffusion Pharmaceuticals Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market
SQI Diagnostics Inc., today reported its financial and operational results for the three and nine months ended June 30, 2016.. SQI is a Toronto-based life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced multiplexed diagnostics. Said Andrew Morris, SQI's President and CEO: "Our transformation from an R&D company to a company with recurring revenue is accelerating."/>
SQI Diagnostics Reports Third Quarter 2016 Results
ARCA biopharma, Inc., a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that the 100 th patient has been randomized into GENETIC-AF, a seamless..."/>
ARCA biopharma Announces 100th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial
WellCare Health Plans, Inc. today announced that the National Committee for Quality Assurance has awarded its Medicare Advantage health plans in Arkansas, Mississippi and Tennessee a status of Accredited. NCQA accreditation evaluates the quality of health care that health plans provide to their members. It is a nationally recognized evaluation that consumers can use to assess health plans."/>
WellCare Receives NCQA Quality Accreditation for Its Medicare Advantage Health Plans in Arkansas, Mississippi and Tennessee
Aytu BioScience Inc., a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it will present at the Rodman& Renshaw 18 th Annual Global Investment Conference, held September 11-13, 2016, at the Lotte New York Palace Hotel in New York City. Chief Executive Officer Josh Disbrow will provide an overview of the company's business during a live presentation and..."/>
Aytu BioScience to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Biocept, Inc., a molecular diagnostics company commercializing biomarkers to improve the detection and treatment of cancer, announces that Veena Singh, M.D., Senior Vice President and Senior Medical Director of Biocept, will present "Liquid Biopsy: Providing Answers that Matter" on August 25, 2016 at the Next Generation Dx Summit being held at the Grand Hyatt Hotel in Washington, D.C. "Liquid biopsies allow for the identification and monitoring of..."/>
Biocept to Present at Next Generation Dx Summit
Organovo Holdings, Inc., a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3 D bioprinting technology, today announced that its board of directors has appointed two new members. Mark Kessel, co-founder and partner of Symphony Capital LLC, and Richard Maroun, executive partner at Frazier Healthcare Partners, will join Organovo’ s board, effective today. The appointments increase the number of..."/>
Organovo Appoints Two New Members to Board of Directors
Intuitive Surgical said on Wednesday that the compensation committee of the board of directors has announced equity awards to 85 new employees under the NASDAQ Marketplace Rule 5635 (c). The company added that the 85 employees were granted a combination of Restricted Stock Units and stock options to purchase an aggregate of 10,222 shares of its common stock; The 5,195 of the shares granted were stock options and 5,027 of the shares granted were RSUs."/>
Intuitive Surgical awards equity options to 85 new employees for August 2016
Masimo announced today the CE Marking of RAS-45, a single-use adult and pediatric acoustic respiration sensor for rainbow Acoustic Monitoring ® of respiration rate. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160818005451/en/."/>
Masimo Announces CE Marking for RAS-45 Sensor for rainbow Acoustic Monitoring® of Respiration Rate
Valeant Pharmaceuticals International, Inc. today announced that it has obtained the requisite lender approval for an amendment to its credit facility. The Company expects to close the amendment next week, subject to customary closing conditions. reduce the interest coverage maintenance covenant to 2.0 x, providing additional headroom provide additional flexibility to sell assets permit the issuance of secured notes with shorter..."/>
Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Consumer Discretionary665 Articles
Information Technology608 Articles
Financials513 Articles
Health Care359 Articles
Industrials353 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.